Synergy Care Group Ltd 14906025 false 2023-05-31 2024-03-31 2024-03-31 The principal activity of the company is the development of care homes. Digita Accounts Production Advanced 6.30.9574.0 true true false false 14906025 2023-05-31 2024-03-31 14906025 2024-03-31 14906025 bus:Consolidated 2024-03-31 14906025 core:CurrentFinancialInstruments 2024-03-31 14906025 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 14906025 core:AdditionsToInvestments 2024-03-31 14906025 bus:SmallEntities 2023-05-31 2024-03-31 14906025 bus:Audited 2023-05-31 2024-03-31 14906025 bus:FullAccounts 2023-05-31 2024-03-31 14906025 bus:SmallCompaniesRegimeForAccounts 2023-05-31 2024-03-31 14906025 bus:RegisteredOffice 2023-05-31 2024-03-31 14906025 bus:Director1 2023-05-31 2024-03-31 14906025 bus:Director2 2023-05-31 2024-03-31 14906025 bus:PrivateLimitedCompanyLtd 2023-05-31 2024-03-31 14906025 core:Subsidiary1 2023-05-31 2024-03-31 14906025 core:Subsidiary1 1 2023-05-31 2024-03-31 14906025 1 2023-05-31 2024-03-31 14906025 countries:EnglandWales 2023-05-31 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 14906025

Prepared for the registrar

Synergy Care Group Ltd

Annual Report and Financial Statements

for the Period from 31 May 2023 to 31 March 2024

 

Synergy Care Group Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 7

 

Synergy Care Group Ltd

Company Information

Directors

S T Day

N J Patel

Registered office

Argyle House
Joel Street
Northwood
HA6 1NW

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Synergy Care Group Ltd

(Registration number: 14906025)
Balance Sheet as at 31 March 2024

Note

2024
£

Fixed assets

 

Investments

4

1

Current assets

 

Debtors

5

560

Cash at bank and in hand

 

751

 

1,311

Creditors: Amounts falling due within one year

6

(5,012)

Net current liabilities

 

(3,701)

Net liabilities

 

(3,700)

Capital and reserves

 

Called up share capital

101

Profit and loss account

(3,801)

Shareholders' deficit

 

(3,700)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 10 December 2024 and signed on its behalf by:
 


N J Patel
Director

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Period from 31 May 2023 to 31 March 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Argyle House
Joel Street
Northwood
HA6 1NW

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of Acacia Care Investments Limited.

The financial statements of Acacia Care Investments Limited may be obtained from Companies House.

Disclosure of long or short period

The financial statements cover a period of 306 days. This is to bring the year end in line with that of the rest of the group.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Period from 31 May 2023 to 31 March 2024

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquiisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Period from 31 May 2023 to 31 March 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Period from 31 May 2023 to 31 March 2024

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was as follows:

Subsidiaries

£

Cost

Additions and as at 31 March 2024

1

Carrying amount

At 31 March 2024

1

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2024

Subsidiary undertakings

Synergy Care Developments Ltd

England and Wales

Ordinary

100%

The principal activity of Synergy Care Developments Ltd is that of a property development company.

Synergy Care Developments Ltd has the same registered office as Synergy Care Group Ltd.

 

5

Debtors

31 March 2024
 £

Other debtors

560

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Period from 31 May 2023 to 31 March 2024

 

6

Creditors

31 March 2024
 £

Due within one year

Amounts due to group undertakings

5,012

 

7

Parent and ultimate parent undertaking

The company's immediate parent is Acacia Care Investments Ltd, incorporated in England and Wales.

 The ultimate controlling party is the director, N J Patel.

 

8

Disclosure under Section 444 (5B) CA 2006 relating to the independent auditor's report

As permitted by Section 444 CA 2006, these accounts do not contain a copy of the company’s Profit and Loss account or a copy of the Directors’ Report. Accordingly, the Independent Auditors’ Report has also been omitted.

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 12 December 2024 was Joanne Hartness, who signed for and on behalf of Hazlewoods LLP.